When facing an illness, one of the first things that patients and caregivers do is go online for information, writes Dawn Lacallade, chief social strategist and pharma practice lead at social media specialist LiveWorld, in an Expert View piece.
Once they’re online, they’re likely to find a treatment community – and stay once they find one that meets their needs. Not only are these groups a tremendous source of information, comfort, and advocacy for millions of people, they offer an unparalleled way for healthcare companies to communicate with their patients and consumers one-to-one.
Facebook’s Mark Zuckerberg recently discussed the value of groups like online treatment communities, saying: “We recently found that more than 100 million people on Facebook are members of what we call ‘very meaningful’ groups. These are groups that upon joining, quickly become the most important part of our social network experience and an important part of our physical support structure.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze